SCHEMBL3613086

SCHEMBL3613086

C=CC[C@@](N)(C(=O)O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.65
TSHR P16473 2/20 0.65
HTT P42858 1/20 0.61
KMT2A Q03164 4/20 0.48
MEN1 O00255 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 1/20 0.43
HIF1A Q16665 2/20 0.41
CYP2C19 P33261 3/20 0.41
GRM5 P41594 1/20 0.39
GRM1 Q13255 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 2/20 0.38
KCNN4 O15554 1/20 0.38
HSD17B10 Q99714 1/20 0.38
AKT1 P31749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1908316 1.00 ALDH1A1 (0.65) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL4813600 0.85 ALDH1A1 (0.46) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL2987235 0.81 HTT (0.53) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL3617440 0.79 HTT (0.50) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL3617442 0.79 HTT (0.50) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL7715181 0.78 ALDH1A1 (0.67) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL5325708 0.78 ALDH1A1 (0.67) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL8358191 0.78 ALDH1A1 (0.67) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL7385780 0.78 ALDH1A1 (0.67) ALDH1A1TSHRHTTKMT2AMEN1
SCHEMBL7769347 0.78 ALDH1A1 (1.00) ALDH1A1TSHRHTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7666862-B2 2,4-Diphenyl-1-(hexamethylenimin-4-ylaminocarbonyl)dihydropyrrole derivatives that are useful for treating cancer MERCK & CO., INC. (US) 2010-02-23 US disclosed
US-7638549-B2 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropyrrolidin3-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide; antiproliferative and -carcinogenic agents MERCK & CO. INC. (US) 2009-12-29 US disclosed
US-20080199459-A1 Mitotic Kinesin Inhibitors MERCK SHARP & DOHME CORP. 2008-08-21 US disclosed
US-7235580-B2 Mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-06-26 US disclosed
US-20060287302-A1 Mitotic kinesin inhibitors MERCK SHARP & DOHME CORP. 2006-12-21 US disclosed
US-20060100191-A1 Mitotic kinesin inhibitors MERCK SHARP & DOHME CORP. 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080199459-A1 Mitotic Kinesin Inhibitors KIF5B, KIF2C, KIF18B ALDH1A1 2302/4885TSHR 4772/4885HTT 986/4885
US-20060100191-A1 Mitotic kinesin inhibitors KIF5B, KIF2C, KIF18B ALDH1A1 2302/4885TSHR 4772/4885HTT 986/4885
US-20060287302-A1 Mitotic kinesin inhibitors KIF5B, KIF2C, KIF18B ALDH1A1 2302/4885TSHR 4772/4885HTT 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.